Functional mitral regurgitation in patients with chronic heart failure: relationship to left ventricular and left atrial structural and functional parameters  by Nikitin, Nikolav P. et al.
130A ABSTRACTS - Cardiac Function and Heart Failure JACC 
1014-155 Functional Mitral Regurgitatlon in Patlents With Chronic 
Heart Failure: Reiatlonship to Left Ventricular and Left 
Atrlai Structural and Functional Parameters 
s, Klaus K. Witte, Simon D. Thackray, Mohammad F. Alamgir, Lindsey J. 
Goodge. Andrew L. Clark, John G. Cleland, The Univeraify of Hu//, Kingston-Upon-Hull, 
United Kingdom. 
This study was designed to explore the relationship between the severity of functional 
mitral regurgitation (MR) in patients with chronic heart failure (CHF) and indices of left 
ventricular (LV) and left atriai (LA) function obtained with the use conventional and new 
echocardiographic techniques. 
Methoda: 73 patients (age 69ilO years, 13 women) with clinically stable CHF (LV eiec- 
tion fraction <45%) underwent echocardlography including coiour tissue Doppler imaging 
(TDI). The presence and magnitude of MR was semi-quantitatively assessed by coiour 
Doppler flow mapping, and the MR jet area was used as a measure of MR severity. Miirai 
annular systolic (S,), early diastolic (E,) and late diastolic (A,,,) velocities were mea- 
sured using TDI at six sites in three apical views and averaged. 
Reaulta. Patients were divided into three subgroups (mild, moderate and severe MR). 
No significant difference in indices of LV remodeling (LV volumes and sphericity index) 
was found between the groups. LV ejection fraction was significantly higher in the mild 
MR group than in the remaining groups. The maximal LA dimension at end systoie was 
significantly higher, and LA active emptying fraction was significantly reduced in the 
severe MR group than in the two other groups. The majority of patients with severe MR 
demonstrated pseudonormal or restrictive patterns of LV diastolic filling. whereas non- 
restrfctive (impaired relaxation) patterns prevailed in the group of patients with mild MR. 
The severity of functional MR was proportional to E, and was inversely proportional to 
S, and A,. When multivariate analysis was performed, only Err,/& ratio and S, 
emerged as independent and additional predictors of the severity of MR. 
In concluafon, in patients with CHF due to LV systolic dysfunction. indices of global LV 
remodeling and LV ejection fraction do not appear to be closely associated with the 
severity of MR, while indexes reflecting LA morphology and pump function are signifi- 
cantly related to MR. There is a tendency towards more restrictive pattern of LV diastolic 
filling proportional to the severity of MR. Mitral annular velocities which are easy to mea- 
sure using colour TDI are important indicators of the severity of MR. 
were analyzed separately for symptomatic and asymptomatic patients and were com- 
pared with normal controls. 
Results. 61% of patients were in NYHA class I-II, 15% in class Ill, and 4% in class IV. 
Head failure occurred in 24% of patients with transposition of the great arteries (TGA) 
and a Mustard procedure, 34% of patients with L-TGA, 40% of Fontan palliated patients. 
Symptomatic patients had significantly lower maximal work load (496.46 +/- 265.26 vs. 
567.24 +/- 199.31 kilopond-meters, p&04), AT (11.3 t/- 3.5 vs. 13.2 +/- 4.9 ml/kg/min, 
p=O.O093). and V02 max (14.69 +/- 5.03 vs. 20.29 +I- 6.75 mi/kg/min, p < 0.00022). Sys- 
temic ventricular function (SVEF) in symptomatic vs. asymptomatic patients at rest and 
during exercise was, 33.42 +/- 15.67 vs. 46.66 +I- 13.42 (p < 0.00001) and 36.66 +/- 
16.71 vs. 53.33 +I- 14.06 (p < O.OCrgl). Mortality rate was 46% among symptomatic 
patients, and 5% among asymptomatic patients during follow-up. 
Conclusion. Patients with single or systemic right ventricles and heart failure symptoms 
have significant cardiovascular limitation compared to asymptomatic patients, who in turn 
have significant cardiovascular limitation compared to the control population. This study 
suggests the importance of identifying patients with single or systemic right ventricles at 
risk for heart failure and the importance of considering strategies to preserve ventricular 
function. 
1014-158 Hypothermia as an Indicator of Imminent Death in Late 
Stage Congestive Heart Failure 
Moein F. Vaseghi, Said Siadaty, Morteza Naghavi, Mohammad Madjid, $&M~J&& 
Casscells., Division of Cam’iology. University of Texas-Houston, Houston, Texas. 
1014-156 Nonexcitatory Cardiac Contractility Modulation in Heart 
Failure: influence of Stimulated Chamber on 
Hemodynamic and Mechanical Response 
wPaowne, Salvatore Rosanio, Daniel Burkhoff, Yuval Mika, Gabriele Vicedomini, 
Monica Tocchi, Vincenzo Santlneiii, Itzhak Shemer, David Prutchi, Waiid Haddad, 
Yehuda Snir, Shiomo A. Ben-Haim, San R&se/e University Hospital, Milano, /t&-/x 
Technion-Israel Institute of Technology Haifa, Israel. 
Numerous predictors of mortality in CHF patients have been described. but even in com- 
bination the sensitivity and specificity are modest. We noted in a retrospective case-con- 
trol study, that in-hospital CHF death was best predicted by hypothermia, lymphopenia, 
right and left ventricular failure, and hypotension. Here we sought to examine in a cohort 
study if temperature is an independent prognostic variable Methods: We investigated 
medical records of patients (pts) with an ICD code of CHF on their last hospital admission 
between Jan and Dee 96. 35 pts were excluded because of temperature (T) confound- 
ers. Factors affecting outcome were entered into a multiple regression model. Results: 
On admission the mean T of ail 291 pts was 97.3*1 .l “F. The mean T on admission of 
pts who sun/Ned (N=274) was 97.3+1.0 “F, and in the pts who died in hospital (N=17) T 
was 96.6i1.7 “F. An increase of 1 “F on admission correlated with an increase in iikeii- 
hood of survival of 76% (p=O.124). Tricuspid regurgitation (marker used for pulmonary 
hypertension and RV function) was a strong predictor (Exp(B) = 37, p= 0.037). Weaker 
predictors were systolic hypotension (Exp(B)=0.96, p=O.O4), female sex 
(Exp(B)=4.l,p=0.04), azotemia. and creatinine (Exp(B)=1.4, p=O.O03). but not sodium or 
% lymphocytes. Death was also predicted by VT but not by AF or RR variability. Conciu- 
sion: Our two studies using different design have identified hypothermia as a novel, pow- 
erful, univariate and multivariate predictor of in-hospital death of CHF patients. 
Background: Electrical currents applied during the action potential refractory period 
have been shown to modulate contractility in vitro and in viva. We assessed the influence 
of stimulated chamber on the hemodynamic and mechanical effect of these non-excita- 
tory cardiac contractility modulating (CCM) signal in patients with chronic heart failure. 
Methods: CCM signals were monophasic square-wave pulses with adjustable ampli- 
tude, duration and time delay from sensing of local electrical activity. Signals were 
applied to the LV through an epicardial vein (12 patients) or to the right ventricular (RV) 
septum endocardially (6 patients). Simultaneous LV and aortic pressures measurements 
were performed by a Millar catheter. Hemodynamics during right-sided DDD pacing was 
regarded as control condition. Results: With LV stimulation, 2 patients complained of 
chest discomfort at 10mA CCM amplitude, which was abolished at 6mA in one patient, 
while in the other a further reduction to 6mA was necessary. With RV stimulation, no 
symptoms occurred and it was possible to use 14mA CCM in all patients. Both LV and 
RV CCM stimulation enhanced dP/dt,,,,, to a similar degree (6.6* 5.4% and 6.6* 0.5%, 
respectively, PcO.01 vs control), with associated pulse pressure changes of tO.3i 7.2% 
and 10.6f. 1.4% (PcO.01 vs control). Echo color kinesis, a technique for quantifying glo- 
bal and regional systolic function, demonstrated an overall increase in the magnitude and 
velocity of contraction in both groups, expressed by significant (PcO.05) increase in glo- 
bal fractional area change in 56 of end-diastolic area (LV 22f5% vs. RV 23-t4%. P=NS) 
and peak ejection rate and shortening in time-to-peak ejection rate. The magnitude of 
regional systolic endocardiai motion was markedly enhanced near the CCM electrode, 
with a lesser but significant improvement in remote regions as well. Conclusions: Local 
CCM stimulation of LV or RV myocardium enhances global LV systolic performance to a 
similar degree. The right-sided approach may be associated with less symptoms and 
penit use of higher current amplitudes, which correlate with stronger contractile 
enhancement in experimental preparations. 
1014-158A Risk Stratification Using A Combinatlon of Cardiac 
Troponin T and Brain Natriuretic Peptkle After 
Optimized Treatment in Patients with Advanced Heart 
Failure 
Junnlchl, Masanori Nomura, Yuu Nakamura, Hiroyuki Naruse, Yoshihisa Mod, 
Toshikazu Ando, Hiroshi Kurokawa, Takeshi Kondo, Hi&hi Hishida, Fujita Health 
Universitv, Toyoake, Japan. 
1014-157 Heart Failure and Ventrlcuiar Dysfunction in Patients 
With Single and/or Systemic Right Ventricles 
mPiran, Gruschen Veldtman, Gary D. Webb, Peter P. Liu, Congenital Cardiac 
Centre and Heart B Stroke/RL Center of Excellence, University of Toronto, Toronto, 
Ontario, Canada. 
Background, and Objectives. Previous studies have shown an increased incidence of 
congestive heart failure and mortality in patients with single and/or systemic right ventri- 
cles. We sought to characterize ventricular dysfunction as well as overt heart failure in 
this population. 
Methods. 193 consecutive adult patients with a single and/or systemic right ventricle 
were identified from the database of the University of Toronto Congenital Cardiac Centre 
for Adults (UTCCCA). The patients were assessed with gated radionuciide angiography 
(137) or 2-D echocardiographic (193). Hospital records were reviewed for the following 
clinical endpoints of maximal oxygen uptake (V02 max), anaerobic threshold (AT), a his- 
tory of heart failure, and the presence of heart failure on chest radiograph (CXR). Data 
Background: The aim of this study was to evaluate whether repetitive measurements of 
cardiac troponin T (TnT) and brain natriuretic peptide (BNP) before and after optimized 
treatment are useful for risk stratification in patients (pts) with congestive heart failure 
(CHF). Methods: Levels of TnT and BNP and left ventricular ejection fraction (EF) were 
measured both on admission and on discharge in 93 consecutive pts hospitalized for 
worsening CHF (mean age 69 yrs, NYHA class ii in 24 pts, Iii in 46, IV in 23). Pts were 
monitored for a mean follow-up period of 272 days after discharge. Results: The detec- 
tion rate of TnT (>O.Ol @ml), TnT and BNP levels, EF and NYHA class on discharge 
(mean length of hospital stay 36 days) were improved compared with the value on 
admission (detection rate of TnT: 39 YS 60%: TnT: 0.03 vs 0.07; BNP: 267 vs 725 pg/ml; 
EF: 45 vs 40%; NYHA class: 2.2 vs 3.0; p<O.Oi). During the follow-up period, there were 
36 (39%) cardiac events (9 cardiac deaths and 27 readmissions for worsening CHF). In a 
stepwise Cox regression analysis including TnT, log BNP, EF and NYHA class on admis- 
sion and discharge, age and sex, TnT (p=O.o003) and log BNP (p=O.O4) on discharge 
were independent predictors of cardiac event. Using discharge values of TnT (> or < 
0.01: T+ or T-) and BNP (> or < 160: B+ or B-) determined by ROC curves, the pts were 
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